Developed & Manufactured by Biomedica
img

Measure total soluble Neuropilin-1 in biological samples

19 March, 2019

Biomedica is happy to introduce the only Neuropilin-1 ELISA that measures total soluble NRP1 utilizing specific EPITOPE MAPPED ANTIBODIES.

Assay Highlights:

  • HIGHLY SPECIFIC and DEFINED – epitope mapped antibodies
  • RELIABLE: human serum based calibrators and controls, rigorously validated
  • LOW SAMPLE VOLUME: 10 µl / well
  • QUICK: total incubation time 4 h
  • PROTOCOLS available for urine, cc supernatants and non-human samples

Areas of interest: oncology, nephrology, osteology, cardiology

For detailed information please click corresponding links:

BI-20409 total soluble Neuropilin-1 product website
BI-20409 total soluble Neuropilin-1 ELISA IFU
BI-20409 total soluble Neuropilin-1 ELISA Validation Data
BI-20409 total soluble Neuropilin-1 ELISA MSDS

Biomedica ELISA Service Quotation Form

Share:
Related NEWS:
17 February , 2020
Biomedica @ Osteologie 2020 in Salzburg
5 February , 2020
High circulating levels of Periostin are associated with a poor survival in primary, non-metastatic breast cancer patients
30 January , 2020
C4d is prognostic of cardiac allograft vasculopathy
13 January , 2020
FGF23: a Novel Risk Marker of Heart Failure.
Categories

Receive the latest biomedica news

We share latest news and upcoming events: